Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
A Randomized Phase II Study of Temozolomide or Temozolomide and Capecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors.
Open to Accrual
Defintions of terms and FAQ about clinical trials.
Syma Iqbal, M.D.
Other Trial Staff:
Marile Garcia, Coordinator, Noureddine Miloud, D.M., Catherine Ticong, R.N.
to see study documents.
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.